News
Stories about the companies we track, gathered daily from UK and European tech press and Google News. Headlines link to the original publisher.
22 storiesAlchemab Therapeutics ✕
Clear all- LeadershipBioSpace, 10 Sept 2026Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline
- OtherHealthcare Today, 22 Jul 2026Capital raising in healthtech: Healome Therapeutics, Alchemab Therapeutics
- Fundingcambridgeindependent.co.uk, 16 Jul 2026£25m Series A boost is a huge vote of support for Alchemab’s resiliomics
- FundingBusiness Wire, 8 Jul 2026Alchemab Therapeutics Announces Largest Ever Life Sciences Investment From British Business Bank to Advance AI-Enabled Clinical Pipeline of Next Generation Human-Derived Antibodies
- OtherCambridge Independent, 25 Mar 2026Alchemab welcomes new CBO with senior Sanofi expertise
- OtherHealthInvestor UK, 21 Mar 2026Alchemab Therapeutics: Ulrich Wendt
- Leadershipcontractpharma.com, 17 Mar 2026Alchemab Appoints Ulrich Wendt as Chief Business Officer
- ProductBusiness Weekly, 17 Mar 2026Alchemab Therapeutics unveils Sanofi executive coup to fuel growth
- OtherBioXconomy, 17 Sept 2025Alchemab banks $32m cash injection to advance antibody pipeline
- OtherCambridge Independent, 16 Sept 2025Phase 1 success and $32m finance boost for Alchemab Therapeutics
- FundingEuropean Biotechnology Magazine, 10 Sept 2025Alchemab Therapeutics reports US$32m Series A extension
- OtherPharmaceutical Executive, 9 Sept 2025Alchemab Advances AI-Enabled Antibody Platform with Phase I Trial, $32 Million Financing Boost
- ExpansionManufacturing Chemist, 7 May 2025Eli Lilly licenses Alchemab Therapeutics' ALS therapeutic antibody, ATLX-1282, for $415m
- OtherPMLiVE, 7 May 2025Eli Lilly and Alchemab Therapeutics enter ALS agreement worth up to $415m
- OtherPharmaceutical Executive, 6 May 2025Lilly Bolsters ALS Pipeline Through $415 Million Licensing Agreement with Alchemab Therapeutics
- OtherMedCity News, 6 May 2025Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect
- Partnerships & dealsBioSpace, 6 May 2025Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
- Partnerships & dealsFirstWord, 6 May 2025Lilly inks another antibody deal with Alchemab in ALS
- ExpansionFierce Biotech, 6 May 2025Eli Lilly licenses early-stage ALS drug program from Alchemab in $415M pact
- Partnerships & dealsPharmaceutical Technology, 6 May 2025Eli Lilly signs $415m deal for Alchemab’s ALS therapy
- Otherpharmaphorum, 6 May 2025Lilly forges a $415m ALS alliance with UK biotech Alchemab
- Partnerships & dealsEuropean Medical Journal, 6 May 2025Lilly partners with Alchemab for ALS candidate
